# Cumberland Pharmaceuticals Inc: Form 8-K, filed Feb 4, 2026

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2026-02-04
- Accepted by EDGAR: Feb 4, 2026, 17:20 ET
- Period: 2026-02-04
- Accession: 0001087294-26-000011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000011/cpix-20260204.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000011/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000108729426000011/cpix-20260204.htm

Filed Feb 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001087294-26-000011. Last ingested by Listed: Nov 14, 2026, 23:39 ET. No prices; not investment advice.
